
Malin Alsved
Postdoctoral Fellow

SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission
Author
Summary, in English
BACKGROUND: Covid-19 transmission via exhaled aerosol particles has been considered an important route for the spread of infection, especially during super-spreading events involving loud talking or singing. However, no study has previously linked measurements of viral aerosol emissions to transmission rates.
METHODS: During Feb-Mar 2021, covid-19 cases that were close to symptom onset were visited with a mobile laboratory for collection of exhaled aerosol particles during breathing, talking and singing, respectively, and of nasopharyngeal and saliva samples. Aerosol samples were collected using a BioSpot-VIVAS and a NIOSH bc-251 two-stage cyclone, and all samples were analyzed by RT-qPCR for SARS-CoV-2 RNA detection. We compared transmission rates between households with aerosol-positive and aerosol-negative index cases.
RESULTS: SARS-CoV-2 RNA was detected in at least one aerosol sample from 19 of 38 (50%) included cases. The odds ratio of finding positive aerosol samples decreased with each day from symptom onset (OR 0.55, 95CI 0.30-1.0, p=0.049). The highest number of positive aerosol samples were from singing, 16 (42%), followed by talking, 11 (30%), and the least from breathing, 3 (8%). Index cases were identified for 13 households with 31 exposed contacts. Higher transmission rates were observed in households with aerosol-positive index cases, 10/16 infected (63%), compared to households with aerosol-negative index cases, 4/15 infected (27%) (Chi-square test, p=0.045).
CONCLUSIONS: Covid-19 cases were more likely to exhale SARS-CoV-2-containing aerosol particles close to symptom onset and during singing or talking as compared to breathing. This study supports that individuals with SARS-CoV-2 in exhaled aerosols are more likely to transmit covid-19.
Department/s
- Ergonomics and Aerosol Technology
- Metalund
- NanoLund: Center for Nanoscience
- Translational infection medicine
- EpiHealth: Epidemiology for Health
- Clinical Virology, Malmö
- Infection Medicine (BMC)
Publishing year
2022-03-10
Language
English
Pages
50-56
Publication/Series
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume
75
Issue
1
Document type
Journal article
Publisher
Oxford University Press
Topic
- Infectious Medicine
Status
Published
Research group
- Translational infection medicine
- Clinical Virology, Malmö
ISBN/ISSN/Other
- ISSN: 1537-6591